Delivery Order SPE2DR25D2005-SPE2DR26FF1D9
- Not listed
- The Defense Logistics Agency awarded a $5,351.66 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 9, 2026, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. The contract is scheduled for completion by January 12, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order was awarded on a non-competitive basis as a child order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,637.73 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, set to be completed by November 12, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used in medical settings...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,141.92 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Phytonadione...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $3,135.58. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 13, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a...
- The Defense Logistics Agency awarded a $21,587.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for phytonadione 1 mg/0.5 mL syringes with an ultimate completion date of September 9, 2025. Phytonadione, commonly known as vitamin K1, is a critical pharmaceutical used for blood clotting disorders and vitamin K deficiency treatment. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for Phytonadione 1 mg/0.5 mL syringes with a contract ceiling value of $6,851.88. This is a firm fixed price delivery order with an ultimate completion date of June 4, 2025, and represents a non-set-aside competitive award. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical...
- The Defense Logistics Agency awarded a delivery order valued at $7,493.60 to AmerSourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL unit doses. This contract was competitively awarded with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of January 13, 2026. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as the company's corporate office and primary distribution hub. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $20,559.12. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $1,452.64 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Phytonadione 10 mg/ml ampules. This is a firm fixed price contract with no set-aside designation, classified as a child contract under a larger vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. Phytonadione, commonly known as Vitamin K1, is a critical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,454.71 on September 10, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. This firm fixed price, competitively awarded contract is a child order under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at the contractor's corporate office...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF1D9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 20, 2026, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $2,714.85. Phytonadione, a vitamin K1 derivative, is a critical pharmaceutical used in medical settings for coagulation management and treatment of vitamin K deficiency. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is located in Conshohocken, Pennsylvania, where AmerSourceBergen's corporate office is headquartered. This delivery order is issued under AmerSourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026. AmerSourceBergen, a subsidiary of parent company Cencora, Inc., serves as a critical vendor for federal medical procurement and supplies pharmaceutical products across multiple therapeutic domains to military healthcare systems and other government agencies. The company's contract portfolio with DLA demonstrates its capability to fulfill diverse pharmaceutical supply requirements supporting military treatment facilities and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 1/19/26 |